LakeShore Biopharma CEO reports option holdings
LakeShore Biopharma Co., Ltd. director and Chief Executive Officer Wang Xu reported an initial holding of a stock option in a Form 3.
Rhea-AI Filing Summary
LakeShore Biopharma Co., Ltd. director and Chief Executive Officer Wang Xu reported an initial holding of a stock option in a Form 3. The option gives the right to acquire 203,464 ordinary shares at an exercise price of $1.225 per share and expires on December 13, 2034.
According to the vesting terms, 25% of the underlying shares vest on December 31, 2024, and the remaining 75% vest in three equal annual installments on each anniversary of the December 13, 2024 grant date, contingent on continued service with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Wang Xu
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 203,464 contracts (Direct)
Footnotes (1)
- F1. The option vests as to 25% of the underlying shares on December 31, 2024, and the remaining 75% vests in three equal annual installments on each anniversary of the grant date (December 13, 2024) thereafter, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Underlying shares: 203,464 shares
Exercise price: $1.225 per share
Option expiration: December 13, 2034
+2 more
5 metrics
Underlying shares
203,464 shares
Ordinary shares underlying reported option
Exercise price
$1.225 per share
Exercise price of share option
Option expiration
December 13, 2034
Expiration date of share option
Initial vesting tranche
25% of underlying shares
Vesting on December 31, 2024
Remaining vesting
75% of underlying shares
In three equal annual installments after December 13, 2024
Key Terms
Share Option (Right to Buy), underlying shares, vesting, expiration date
4 terms
vesting financial
"The option vests as to 25% of the underlying shares on December 31, 2024"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2034-12-13T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LakeShore Biopharma (LSB) disclose about Wang Xu in this Form 3?
LakeShore Biopharma reported that CEO and director Wang Xu holds a stock option covering 203,464 ordinary shares. The option is reported as a direct holding and reflects his initial derivative ownership position with the company in this regulatory filing.
What is the exercise price of Wang Xu’s LakeShore Biopharma (LSB) option?
The exercise price of Wang Xu’s option is $1.225 per ordinary share. This means he can purchase each underlying share at $1.225 once the option has vested and before expiration, subject to the company’s equity plan terms and his continued service.
When does Wang Xu’s LakeShore Biopharma (LSB) option vest?
The option vests 25% of its underlying shares on December 31, 2024. The remaining 75% then vests in three equal annual installments on each anniversary of the December 13, 2024 grant date, provided Wang Xu continues to serve the company.
When does Wang Xu’s LakeShore Biopharma (LSB) option expire?
The reported stock option held by Wang Xu expires on December 13, 2034. He must exercise vested portions of the option before that expiration date; otherwise, any unexercised rights to purchase underlying ordinary shares will lapse automatically.
Is Wang Xu’s LakeShore Biopharma (LSB) option a direct or indirect holding?
The filing identifies the stock option as a direct holding by Wang Xu. The ownership code is listed as “D” for direct, with no footnote indicating any trust, partnership, or other entity holding the derivative security on his behalf.
AI-generated analysis. How Rhea-AI works. Not financial advice.
